Nurix Therapeutics, Inc. NRIX Accrued Progress Collections and Price Adjustments
Accrued Progress Collections and Price Adjustments at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments?
- Nurix Therapeutics, Inc. (NRIX) reported accrued progress collections and price adjustments of $7.59M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments changed year-over-year?
- Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments decreased by 68.6% year-over-year, from $24.15M to $7.59M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s accrued progress collections and price adjustments has grown at a -30.3% compound annual growth rate (CAGR), from $60.69M to $10.01M.